Blockbuster weight loss drug Mounjaro launched, prices starts at Rs 3500 per vial NEW DELHI: Pharma major Eli Lilly on Thursday announced the launch of Mounjaro – a blockbuster weight-loss drug that is a big hit in the UK, Europe and other countries already – in India.Mounjaro, an injectable drug that aids weight loss by…
Eli Lilly and Company (Lilly) announced the appointment of Winselow Tucker as president and general manager for Lilly India, effective immediately. Winselow will lead all of Lilly’s operations in India, including the Lilly India commercial organisation and the Lilly Capability Centre India (LCCI) in Bengaluru and Hyderabad, says a company statement.In a related move, Vineet…
NEW DELHI: In good news for those suffering from obstructive sleep apnea (OSA), a condition characterised by disordered breathing during sleep, the US FDA has, for the first time, approved an anti-diabetic drug also used for weight loss, sold under the brand name Zepbound (Tirzepatide), to manage the condition in adults with obesity.Treatments currently for…
NEW DELHI: Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to launch its blockbuster drug – Tirzepatide – in India in 2025.“India presents a promising market, with a large and growing population, rising disease burden from obesity, diabetes, and cancer, and an increasing health expenditure … A…